164 related articles for article (PubMed ID: 6378236)
1. Oral acyclovir prophylaxis against herpes simplex virus in non-Hodgkin lymphoma and acute lymphoblastic leukaemia patients receiving remission induction chemotherapy. A randomised double blind, placebo controlled trial.
Anderson H; Scarffe JH; Sutton RN; Hickmott E; Brigden D; Burke C
Br J Cancer; 1984 Jul; 50(1):45-9. PubMed ID: 6378236
[TBL] [Abstract][Full Text] [Related]
2. Acyclovir given as prophylaxis against oral ulcers in acute myeloid leukaemia: randomised, double blind, placebo controlled trial.
Bergmann OJ; Ellermann-Eriksen S; Mogensen SC; Ellegaard J
BMJ; 1995 May; 310(6988):1169-72. PubMed ID: 7767151
[TBL] [Abstract][Full Text] [Related]
3. Acyclovir prophylaxis against herpes simplex virus infection in patients with leukemia. A randomized, double-blind, placebo-controlled study.
Saral R; Ambinder RF; Burns WH; Angelopulos CM; Griffin DE; Burke PJ; Lietman PS
Ann Intern Med; 1983 Dec; 99(6):773-6. PubMed ID: 6359995
[TBL] [Abstract][Full Text] [Related]
4. Oral acyclovir as prophylaxis for bacterial infections during induction therapy for acute leukaemia in adults. The Leukemia Group of Middle Sweden.
Lönnqvist B; Palmblad J; Ljungman P; Grimfors G; Järnmark M; Lerner R; Nyström-Rosander C; Oberg G
Support Care Cancer; 1993 May; 1(3):139-44. PubMed ID: 8149141
[TBL] [Abstract][Full Text] [Related]
5. Acyclovir prophylaxis against herpes virus infections in severely immunocompromised patients: randomised double blind trial.
Hann IM; Prentice HG; Blacklock HA; Ross MG; Brigden D; Rosling AE; Burke C; Crawford DH; Brumfitt W; Hoffbrand AV
Br Med J (Clin Res Ed); 1983 Aug; 287(6389):384-8. PubMed ID: 6307464
[TBL] [Abstract][Full Text] [Related]
6. Use of acyclovir for prophylaxis of herpes infections in severely immunocompromised patients.
Prentice HG
J Antimicrob Chemother; 1983 Sep; 12 Suppl B():153-9. PubMed ID: 6313594
[TBL] [Abstract][Full Text] [Related]
7. Sequential intravenous and twice-daily oral acyclovir for extended prophylaxis of herpes simplex virus infection in marrow transplant patients.
Shepp DH; Dandliker PS; Flournoy N; Meyers JD
Transplantation; 1987 May; 43(5):654-8. PubMed ID: 3554658
[TBL] [Abstract][Full Text] [Related]
8. Oral acyclovir in the suppression of recurrent non-genital herpes simplex virus infection.
Meyrick Thomas RH; Dodd HJ; Yeo JM; Kirby JD
Br J Dermatol; 1985 Dec; 113(6):731-5. PubMed ID: 3913459
[TBL] [Abstract][Full Text] [Related]
9. Oral acyclovir for prevention of herpes simplex virus reactivation after marrow transplantation.
Wade JC; Newton B; Flournoy N; Meyers JD
Ann Intern Med; 1984 Jun; 100(6):823-8. PubMed ID: 6326632
[TBL] [Abstract][Full Text] [Related]
10. Acyclovir prophylaxis and fever during remission-induction therapy of patients with acute myeloid leukemia: a randomized, double-blind, placebo-controlled trial.
Bergmann OJ; Mogensen SC; Ellermann-Eriksen S; Ellegaard J
J Clin Oncol; 1997 Jun; 15(6):2269-74. PubMed ID: 9196140
[TBL] [Abstract][Full Text] [Related]
11. Acyclovir and renal transplantation.
Pettersson E; Eklund B; Höckerstedt K; Salmela K; Ahonen J
Scand J Infect Dis Suppl; 1985; 47():145-8. PubMed ID: 3912970
[TBL] [Abstract][Full Text] [Related]
12. Once-daily intravenous acyclovir for prophylaxis of herpes simplex virus reactivation after marrow transplantation.
Shepp DH; Dandliker PS; Flournoy N; Meyers JD
J Antimicrob Chemother; 1985 Sep; 16(3):389-95. PubMed ID: 2997101
[TBL] [Abstract][Full Text] [Related]
13. Oral acyclovir prophylactic treatment of herpes simplex infection after bone marrow transplantation.
Gluckman E; Lotsberg J; Devergie A; Zhao XM; Melo R; Gomez-Morales M; Mazeron MC; Perol Y
J Antimicrob Chemother; 1983 Sep; 12 Suppl B():161-7. PubMed ID: 6313595
[TBL] [Abstract][Full Text] [Related]
14. Prevention of herpesvirus infections in renal allograft recipients by low-dose oral acyclovir.
Seale L; Jones CJ; Kathpalia S; Jackson GG; Mozes M; Maddux MS; Packham D
JAMA; 1985 Dec; 254(24):3435-8. PubMed ID: 2999455
[TBL] [Abstract][Full Text] [Related]
15. Prevention of herpes simplex virus (HSV) infection in recipients of HLA-matched T-lymphocyte-depleted bone marrow allografts.
Engelhard D; Morag A; Or R; Naparstek E; Cividalli G; Ruchlemer R; Aker M; Maayan S; Slavin S
Isr J Med Sci; 1988 Mar; 24(3):145-50. PubMed ID: 3286577
[TBL] [Abstract][Full Text] [Related]
16. A randomized, placebo-controlled trial of oral acyclovir for the prevention of cytomegalovirus disease in recipients of renal allografts.
Balfour HH; Chace BA; Stapleton JT; Simmons RL; Fryd DS
N Engl J Med; 1989 May; 320(21):1381-7. PubMed ID: 2541335
[TBL] [Abstract][Full Text] [Related]
17. Oral acyclovir for treatment of first-episode herpes simplex virus proctitis.
Rompalo AM; Mertz GJ; Davis LG; Benedetti J; Critchlow C; Stamm WE; Corey L
JAMA; 1988 May; 259(19):2879-81. PubMed ID: 3367455
[TBL] [Abstract][Full Text] [Related]
18. Oral acyclovir therapy for mucocutaneous herpes simplex virus infections in immunocompromised marrow transplant recipients.
Shepp DH; Newton BA; Dandliker PS; Flournoy N; Meyers JD
Ann Intern Med; 1985 Jun; 102(6):783-5. PubMed ID: 2986508
[TBL] [Abstract][Full Text] [Related]
19. Acyclovir prophylaxis of herpes-simplex-virus infections.
Saral R; Burns WH; Laskin OL; Santos GW; Lietman PS
N Engl J Med; 1981 Jul; 305(2):63-7. PubMed ID: 6264292
[TBL] [Abstract][Full Text] [Related]
20. Acyclovir prophylaxis in bone marrow transplant recipients.
Lundgren G; Wilczek H; Lönnqvist B; Lindholm A; Wahren B; Ringdén O
Scand J Infect Dis Suppl; 1985; 47():137-44. PubMed ID: 3006228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
